Latest News about atai

Recent news which mentions atai

...

13 14 15 16 17 18 19 20 Next >

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation

October 18, 2021

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are

October 13, 2021

Here are Citi’s 10 fresh ways to play disruption — including psychedelic drugs

October 12, 2021

What Is Precision Psychiatry? Biotech Company Leverages New Approach To Mental Health Disorders

October 11, 2021

Atai Life Launches Depression-Focused Firm

October 11, 2021

Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery

October 11, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study

September 27, 2021

Can Ibogaine Treat Opioid Addiction? Nasdaq-Listed Atai Is Launching A Trial To Find Out

September 21, 2021

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial

September 20, 2021

Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine

September 14, 2021

Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics

September 13, 2021

Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?

September 09, 2021

What 10 Analyst Ratings Have To Say About ATAI Life Sciences

September 01, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021

September 01, 2021

21 Stocks Moving in Wednesday's Pre-Market Session

September 01, 2021

Where ATAI Life Sciences Stands With Analysts

August 21, 2021

What 9 Analyst Ratings Have To Say About ATAI Life Sciences

August 17, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M

August 16, 2021

Earnings Scheduled For August 16, 2021

August 16, 2021

3 Disruptive Mental Health Stocks to Consider Buying Before They're Huge

August 14, 2021

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

August 13, 2021

Peter Thiel Backed Atai Life Launches New Mental Health Disorders-Focused Company

August 12, 2021

Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary

August 12, 2021

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts

August 10, 2021

Stocks That Hit 52-Week Lows On Monday

August 09, 2021

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.